Rectointercostal Plane Block (RICPB) for Laparoscopic Cholecystectomy

Condition(s) studied

Investigational drug(s) / intervention(s)

Rectointercostal Plane Block: Ultrasound-guided unilateral right-sided rectointercostal plane block (RICPB) will be performed at the end of surgery before emergence from anesthesia. A total of 30 mL of 0.25% bupivacaine will be injected into the rectointercostal plane under ultrasound guidance.

Port-Site Local Anesthetic Infiltration: Conventional port-site local anesthetic infiltration will be performed at the end of surgery according to the study protocol to provide postoperative analgesia.

Study summary

This prospective randomized controlled trial is designed to evaluate the analgesic efficacy of ultrasound-guided rectointercostal plane block (RICPB) in patients undergoing elective laparoscopic cholecystectomy. Patients will be randomized to receive unilateral right-sided RICPB at the end of surgery. Postoperative opioid consumption, Numeric Rating Scale (NRS) pain scores, and postoperative complications will be assessed to determine the effectiveness of RICPB in postoperative pain management.

Eligibility

Primary outcome measure(s)

• Cumulative Postoperative Morphine Consumption — Postoperative 24 hours
  Total morphine consumption administered via patient-controlled analgesia during the first 24 hours after surgery will be recorded.

Trial sites (1)

More Koç University trials in Turkey

Other trials for the same condition